US-based medical device leader, Boston Scientific Corporation (NYSE: BSX), has announced the market launch of its Athletis peripheral balloon dilatation catheter in mainland China. The product is designed for percutaneous transluminal angioplasty (PTA) of the peripheral vascular system and is utilized in the treatment of stenotic lesions in autologous or artificial arteriovenous dialysis pathways. Additionally, it is used for the posterior expansion of stents and covered stents in the peripheral vascular system.
Advantages of High-Pressure Non-Compliant Balloons
Studies have indicated that high-pressure non-compliant balloons have surpassed conventional balloons in hemodialysis access maintenance surgery. Their high burst pressure and non-compliance characteristics allow for better lumen achievement and longer blood flow patency. However, refractory strictures that cannot be fully expanded with high-pressure non-compliant balloons have led to the emergence of ultra-high-pressure balloons.
Features of the Athletis Catheter
The Athletis catheter, a non-compliant balloon with a patented woven balloon design process, allows for ultra-high pressure of up to 40 ATM, providing scratch and puncture resistance properties even when dealing with high-resistance diseases. The leading design enables efficient traversal through severe stenosis lesions while minimizing the effort required to pass through the lesions, ensuring efficient surgery and reducing damage to the lesions. The innovative design of the balloon and push rod also maintains ideal trafficability in a twisted vascular environment, assisting surgeons in handling more complex lesions.
Implications for Peripheral Vascular Treatment in China
The introduction of the Athletis catheter to the Chinese market signifies a significant advancement in the treatment of peripheral vascular diseases. Boston Scientific’s new offering promises to enhance the capabilities of healthcare providers in performing PTA, ultimately benefiting patients undergoing hemodialysis and those requiring treatment for peripheral vascular stenotic lesions.-Fineline Info & Tech
